These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23538192)

  • 21. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
    Yang F; Wong CKH; Luo N; Piercy J; Moon R; Jackson J
    Eur J Health Econ; 2019 Nov; 20(8):1195-1206. PubMed ID: 31338698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
    Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
    Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence.
    Patrick DL; Khalaf KM; Dmochowski R; Kowalski JW; Globe DR
    Clin Ther; 2013 Jun; 35(6):836-45. PubMed ID: 23747076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets.
    Lamu AN
    Eur J Health Econ; 2020 Aug; 21(6):903-915. PubMed ID: 32300999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients.
    Sauerland S; Weiner S; Dolezalova K; Angrisani L; Noguera CM; García-Caballero M; Rupprecht F; Immenroth M
    Value Health; 2009; 12(2):364-70. PubMed ID: 20667063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.
    Kularatna S; Senanayake S; Chen G; Parsonage W
    Health Qual Life Outcomes; 2020 Apr; 18(1):115. PubMed ID: 32349782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
    Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
    Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.
    Cuervo J; Castejón N; Khalaf KM; Waweru C; Globe D; Patrick DL
    Health Qual Life Outcomes; 2014 Oct; 12():147. PubMed ID: 25288099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia.
    Xu RH; Dong D; Luo N; Wong EL; Yang R; Liu J; Yuan H; Zhang S
    Qual Life Res; 2022 May; 31(5):1533-1544. PubMed ID: 34846671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
    Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
    Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
    Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
    Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany.
    Klapproth CP; van Bebber J; Sidey-Gibbons CJ; Valderas JM; Leplege A; Rose M; Fischer F
    Health Qual Life Outcomes; 2020 Dec; 18(1):389. PubMed ID: 33334351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
    Young MK; Ng SK; Mellick G; Scuffham PA
    Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
    Sturkenboom R; Keszthelyi D; Brandts L; Weerts ZZRM; Snijkers JTW; Masclee AAM; Essers BAB
    Qual Life Res; 2022 Apr; 31(4):1209-1221. PubMed ID: 34546554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.